As more autologous cell therapies enter the market, the patient demand for these therapies is increasing exponentially. With an already huge unmet need, current manufacturing eco-systems are not equipped to deal with the sheer quantity and volume of cell products needed to make these therapies truly accessible.

The Decentralized Manufacturing for Cell Therapy Summit is an unparalleled, pioneering event that unites leading manufacturing experts and stakeholders in this exciting emerging field. This ground-breaking summit serves as a platform for sharing and discussing latest advances in automation, digitalization and quality management systems across multiple sites to usher in a new era of cell therapy manufacturing where a decentralized strategy can become a reality.

Whether your team is ahead of the curve and currently pursuing this approach, or if you are looking to gain deeper insights into this field to develop your future manufacturing strategy as you prepare for scale up, don’t miss out on this cutting-edge conference designed to inspire and facilitate the brainstorming of best-in-class approaches to bring readily accessible, more affordable cell therapies to patients sooner.